{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:06:46Z","timestamp":1794020806613,"version":"4.8.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.biopsych.2014.04.010","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T12:04:30Z","timestamp":1398513870000},"page":"572-581","source":"Crossref","is-referenced-by-count":282,"title":["Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers"],"prefix":"10.1016","volume":"78","author":[{"given":"Rainer","family":"Kraehenmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin H.","family":"Preller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pokorny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz X.","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2014.04.010_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrn2345","article-title":"Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms","volume":"9","author":"DeRubeis","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuron.2005.09.025","article-title":"Contributions of the amygdala to emotion processing: From animal models to human behavior","volume":"48","author":"Phelps","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.04.010_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biopsych.2006.05.004","article-title":"Amygdala reactivity and mood-congruent memory in individuals at risk for depressive relapse","volume":"61","author":"Ramel","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-3223(02)01314-8","article-title":"Can\u02bct shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals","volume":"51","author":"Siegle","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1503\/jpn.120060","article-title":"Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: Associations with anhedonia","volume":"38","author":"Stuhrmann","year":"2013","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.61.9.877","article-title":"Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study","volume":"61","author":"Fu","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archgenpsychiatry.2010.144","article-title":"Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder","volume":"67","author":"Victor","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2014.04.010_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpsyc.62.2.146","article-title":"A susceptibility gene for affective disorders and the response of the human amygdala","volume":"62","author":"Hariri","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/mp.2012.19","article-title":"The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-analysis","volume":"18","author":"Murphy","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/appi.ajp.2012.11071105","article-title":"Functional neuroimaging of major depressive disorder: A meta-analysis and new integration of base line activation and neural response data","volume":"169","author":"Hamilton","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.2003.tb07098.x","article-title":"Neuroimaging abnormalities in the amygdala in mood disorders","volume":"985","author":"Drevets","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib14","doi-asserted-by":"crossref","first-page":"14482","DOI":"10.1523\/JNEUROSCI.2409-10.2010","article-title":"Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders","volume":"30","author":"Hahn","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2014.04.010_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2014.04.010_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2014.04.010_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-012-2811-0","article-title":"The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions","volume":"225","author":"Schmidt","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2014.04.010_bib21","article-title":"Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A\/2A receptor agonist psilocybin [published online ahead of print July 16]","author":"Bernasconi","year":"2013","journal-title":"Cereb Cortex."},{"key":"10.1016\/j.biopsych.2014.04.010_bib22","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.04.010_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000131157","article-title":"[Clinical experiences with psilocybin (CY 39 Sandoz)]","volume":"142","author":"Sercl","year":"1961","journal-title":"Psychiatr Neurol (Basel)"},{"key":"10.1016\/j.biopsych.2014.04.010_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02791072.1994.10472600","article-title":"Psychedelic and entactogenic drugs in the treatment of depression","volume":"26","author":"Riedlinger","year":"1994","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.biopsych.2014.04.010_bib26","first-page":"253","article-title":"[Psychotherapy with the aid of hallucinogenic drugs] [German]","volume":"16","author":"Leuner","year":"1966","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopsych.2014.04.010_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1601-183X.2006.00297.x","article-title":"Serotonergic genes modulate amygdala activity in major depression","volume":"6","author":"Dannlowski","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2014.04.010_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: The PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib30","series-title":"Manual for the State-Trait Anxiety Inventory (Form Y) (\u201cSelf-Evaluation Questionnaire\u201d)","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.biopsych.2014.04.010_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/nimg.2002.1179","article-title":"The amygdala response to emotional stimuli: A comparison of faces and scenes","volume":"17","author":"Hariri","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0006-3223(02)01786-9","article-title":"Neocortical modulation of the amygdala response to fearful stimuli","volume":"53","author":"Hariri","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib33","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuropsychologia.2010.10.004","article-title":"Modulating amygdala responses to emotion: Evidence from pharmacological fMRI","volume":"49","author":"Patin","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.biopsych.2014.04.010_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0893-133X(02)00373-1","article-title":"Dextroamphetamine modulates the response of the human amygdala","volume":"27","author":"Hariri","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuroimage.2009.11.069","article-title":"Abnormalities in neural processing of emotional stimuli in Williams syndrome vary according to social vs. non-social content","volume":"50","author":"Mu\u00f1oz","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S1053-8119(03)00169-1","article-title":"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets","volume":"19","author":"Maldjian","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O","article-title":"A unified statistical approach for determining significant signals in images of cerebral activation","volume":"4","author":"Worsley","year":"1996","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2014.04.010_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2014.04.010_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0959-4388(00)00197-5","article-title":"Spatiotemporal mapping of brain activity by integration of multiple imaging modalities","volume":"11","author":"Dale","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1053-8119(03)00078-8","article-title":"Valence, gender, and lateralization of functional brain anatomy in emotion: A meta-analysis of findings from neuroimaging","volume":"19","author":"Wager","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neubiorev.2007.12.002","article-title":"The role of the amygdala in emotional processing: A quantitative meta-analysis of functional neuroimaging studies","volume":"32","author":"Sergerie","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2014.04.010_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainresrev.2004.02.004","article-title":"Lateralization of amygdala activation: A systematic review of functional neuroimaging studies","volume":"45","author":"Baas","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biopsych.2014.04.010_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/jnnp.74.8.1136","article-title":"Increased visual cortical excitability in ecstasy users: A transcranial magnetic stimulation study","volume":"74","author":"Oliveri","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1076\/neur.9.5.436.16557","article-title":"Suppression of complex visual hallucinatory experiences by occipital transcranial magnetic stimulation: A case report","volume":"9","author":"Merabet","year":"2003","journal-title":"Neurocase"},{"key":"10.1016\/j.biopsych.2014.04.010_bib47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cercor\/10.5.529","article-title":"Enhanced excitability of the human visual cortex induced by short-term light deprivation","volume":"10","author":"Boroojerdi","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2014.04.010_bib48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/3738","article-title":"The anatomy of conscious vision: An fMRI study of visual hallucinations","volume":"1","author":"Ffytche","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2010.10.002","article-title":"The 5-HT2A\/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations","volume":"69","author":"Kometer","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib50","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0306-4522(02)01001-1","article-title":"Topographic organization of projections from the amygdala to the visual cortex in the macaque monkey","volume":"118","author":"Amaral","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.04.010_bib52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nn1341","article-title":"Distant influences of amygdala lesion on visual cortical activation during emotional face processing","volume":"7","author":"Vuilleumier","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib53","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0269881113494106","article-title":"Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala","volume":"27","author":"Hornboll","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib54","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2014.04.010_bib55","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm000339w","article-title":"Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines","volume":"43","author":"Blair","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2014.04.010_bib56","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1016\/j.bmcl.2005.06.104","article-title":"SAR of psilocybin analogs: Discovery of a selective 5-HT 2C agonist","volume":"15","author":"Sard","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.biopsych.2014.04.010_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: Implications for neuroplasticity linked to major depression and Alzheimer\u02bcs disease","volume":"172","author":"Michelsen","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.biopsych.2014.04.010_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2012.06.007","article-title":"Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL\/6J mice","volume":"64","author":"Zhang","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","article-title":"Normative database of the serotonergic system in healthy subjects using multi-tracer PET","volume":"63","author":"Savli","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0306-4522(01)00336-0","article-title":"Long-term depression in the basolateral amygdala of the mouse involves the activation of interneurons","volume":"107","author":"Rammes","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.04.010_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuropharm.2013.11.007","article-title":"Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment","volume":"79","author":"Vicente","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/jn.1999.82.1.69","article-title":"Serotonergic modulation of neurotransmission in the rat basolateral amygdala","volume":"82","author":"Rainnie","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib63","doi-asserted-by":"crossref","first-page":"RC8","DOI":"10.1523\/JNEUROSCI.19-11-j0005.1999","article-title":"GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: A mechanism for modulation of sensory inputs related to fear conditioning","volume":"19","author":"Stutzmann","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3565(24)37472-5","article-title":"5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus","volume":"285","author":"Shen","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2014.04.010_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-6997(24)01417-0","article-title":"Autoregulation of serotonin neurons: Role in antidepressant drug action","volume":"51","author":"Pi\u00f1eyro","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2014.04.010_bib66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2014.04.010_bib67","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.npp.1300556","article-title":"Serotonin 1A receptor binding and treatment response in late-life depression","volume":"29","author":"Meltzer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib68","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0969-8051(00)00119-0","article-title":"Serotonin type-1A receptor imaging in depression","volume":"27","author":"Drevets","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib70","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S1461145710000581","article-title":"Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions","volume":"13","author":"Lanzenberger","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib71","article-title":"Disrupted effective connectivity between the amygdala and orbitofrontal cortex in social anxiety disorder during emotion discrimination revealed by dynamic causal modeling for fMRI [published online ahead of print October 9]","author":"Sladky","year":"2013","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2014.04.010_bib72","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.neuroimage.2011.02.064","article-title":"Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder","volume":"56","author":"Hahn","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.04.010_bib73","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/mp.2008.35","article-title":"Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders","volume":"14","author":"Spindelegger","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib74","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.1073\/pnas.0801329105","article-title":"Enhanced contextual fear memory in central serotonin-deficient mice","volume":"105","author":"Dai","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.04.010_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.biopsych.2014.04.010_bib76","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nn1780","article-title":"Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity","volume":"9","author":"Fisher","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2014.04.010_bib77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0028-3908(97)00034-8","article-title":"A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety","volume":"36","author":"Griebel","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2014.04.010_bib79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/npp.2011.198","article-title":"Review of pharmacological treatment in mood disorders and future directions for drug development","volume":"37","author":"Li","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.04.010_bib80","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.04.010_bib81","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neubiorev.2013.07.010","article-title":"Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy","volume":"37","author":"Outhred","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2014.04.010_bib82","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.pnpbp.2010.07.022","article-title":"A cognitive neuropsychological model of antidepressant drug action","volume":"35","author":"Pringle","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314002753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314002753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:29:35Z","timestamp":1746199775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322314002753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0006322314002753"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2014.04.010","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}